MX348746B - Biologically active peptide for repairing and regenerating bone. - Google Patents

Biologically active peptide for repairing and regenerating bone.

Info

Publication number
MX348746B
MX348746B MX2012005314A MX2012005314A MX348746B MX 348746 B MX348746 B MX 348746B MX 2012005314 A MX2012005314 A MX 2012005314A MX 2012005314 A MX2012005314 A MX 2012005314A MX 348746 B MX348746 B MX 348746B
Authority
MX
Mexico
Prior art keywords
repairing
regenerating bone
biologically active
active peptide
peptide
Prior art date
Application number
MX2012005314A
Other languages
Spanish (es)
Other versions
MX2012005314A (en
Inventor
Arzate Higinio
Original Assignee
Univ Nacional Autónoma De México
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nacional Autónoma De México filed Critical Univ Nacional Autónoma De México
Priority to MX2012005314A priority Critical patent/MX348746B/en
Publication of MX2012005314A publication Critical patent/MX2012005314A/en
Publication of MX348746B publication Critical patent/MX348746B/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention pertains to the field of tissue engineering and provides a pharmaceutical composition for the induction of the osteogenesis process for repairing and/or regenerating bone. This formulation includes a physiologically acceptable vehicle, in this case a biodegradable compound based on gelatin having a three-dimensional porous structure along with a peptide of the adhesion protein of the root cementum (CAP/PTPLA) derived from the carboxyl-terminus region, which has an osteoinduction ability to treat bone defects, such as those resulting from traumas, infections, cancer in dental treatments amongst others.
MX2012005314A 2012-05-07 2012-05-07 Biologically active peptide for repairing and regenerating bone. MX348746B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2012005314A MX348746B (en) 2012-05-07 2012-05-07 Biologically active peptide for repairing and regenerating bone.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012005314A MX348746B (en) 2012-05-07 2012-05-07 Biologically active peptide for repairing and regenerating bone.

Publications (2)

Publication Number Publication Date
MX2012005314A MX2012005314A (en) 2013-11-27
MX348746B true MX348746B (en) 2017-06-16

Family

ID=50097421

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012005314A MX348746B (en) 2012-05-07 2012-05-07 Biologically active peptide for repairing and regenerating bone.

Country Status (1)

Country Link
MX (1) MX348746B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017052355A2 (en) * 2015-09-25 2017-03-30 Universidad Nacional Autónoma de México Use of peptide drugs for the treatment of osteoporosis and for bone regeneration

Also Published As

Publication number Publication date
MX2012005314A (en) 2013-11-27

Similar Documents

Publication Publication Date Title
BR112015001782A2 (en) method to produce a composition for treating an injured tooth
WO2017044894A3 (en) Cartilage-homing peptides
BR112014018910A8 (en) PHARMACEUTICAL PRODUCT, KIT, USE OF VEMURAFENIB, PRODUCTS, METHODS, COMPOSITIONS AND INNOVATIVE USES
AU2014290512A8 (en) Methods, systems, and compositions for promoting bone growth
BR112017009405A2 (en) antibiotic compositions.
EP3325029A4 (en) Soy-derived bioactive peptides for use in compositions and methods for wound healing, tissue engineering, and regenerative medicine
TR201901077T4 (en) Combined Preparations for Cancer or Infection Treatment
MX2022010774A (en) Compositions comprising amino acids for use in the treatment of mitochondrial dysfunction-related diseases.
MX2022009155A (en) Novel polymeric hgh prodrugs.
WO2015031726A3 (en) Engineered primate l-methioninase for therapeutic purposes
PE20131065A1 (en) COMBINED PHARMACEUTICAL COMPOSITIONS AND METHOD OF TREATMENT OF VERTIGO, KINETOSIS AND VEGETATIVE-VASCULAR DISTONIA
MX2020011333A (en) Therapeutic use of bone morphogenetic proteins.
BR112013004436A2 (en) compositions and uses of materials with high microbicidal activity and low toxicity
CL2008003545A1 (en) Compounds derived from [(imidazol-1-yl) -1-hydroxy-1-phosphono-ethyl] -phosphonic acid; Preparation method; pharmaceutical composition; and use for the treatment of excessive or inappropriate bone resorption or disease caused by excessive preylation of target proteins.
WO2018081726A3 (en) Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis
WO2012135848A3 (en) Melatonin-based treatment and diagnosis of bile duct disease
BR112017013696A2 (en) peptides and their use in skin treatment
MX2017016227A (en) Broad-spectrum anti-infective peptides.
WO2011163398A3 (en) Biomimetic peptides for bone augmentation
WO2015084883A3 (en) Compositions and methods for treating osteoarthritis
WO2017093810A3 (en) Composition for intraoral delivery of biologically active peptides and proteins
EA201590601A1 (en) APPLICATION OF PEDF-DERIVED POLYPEPTIDES FOR THE TREATMENT OF OSTEOARTHRITIS
WO2015043566A8 (en) Cyclic amyloid-beta-binding peptides and the use thereof
PH12016500708A1 (en) Recombinant glycoproteins and uses thereof
WO2014039074A3 (en) Therapeutic compositions and related methods

Legal Events

Date Code Title Description
FG Grant or registration